Method comparison of Particle Enhanced Immunoturbidimetry (PEIT) with High Performance Liquid Chromatography (HPLC) for glycated hemoglobin (HbA1c) analysis
Authors:
Open Access
- 13 June 2021
- journal article
- research article
- Published by Springer Nature in Clinical Diabetes and Endocrinology
- Vol. 7 (1) , 1-5
Abstract
Background and objective: High Performance Liquid Chromatography (HPLC) technique is considered as a gold standard for HbA1c analysis however all laboratories cannot adopt it due to certain limitations. Our aim was to compare Particle Enhanced Immunoturbidimetry (PEIT) method with High Performance Liquid Chromatography (HPLC) for HbA1c analysis. Method: All blood samples were analyzed by HPLC assay on a Bio-Rad D-10 analyzer and PEIT on an Erba XL-200 analyzer. Precision studies were undertaken and Coefficient of Variation (%CV) calculated. Systemic Error (SE), Random Error (RE) and Total Error (TEcalc) were obtained. The Total Allowable Error (TEa) set by the National Glycohemoglobin Standardization Program (NGSP) for HbA1c is 6%.The acceptable evaluation method is where TEcalc is less than TEa. Results: The Precision studies were satisfactory with Coefficient of Variation (%CV) being less than 4% for both techniques. Mean HbA1c levels were slightly higher from HPLC than PEIT 9.07 ± 2.23% and 8.93 ± 2.10% respectively, although the difference was minimal. RE was 1.41%, TEcalc was 1.55%, which was less than TEa set by the NGSP. Both methods strongly correlated with the correlation coefficient (r) 0.9716, p < 0.0001. Conclusion: Our study showed HbA1c analysis by PEIT technique is precise, accurate, rapid and convenient and can be employed as an alternative to HPLC technique in countries where cost is a major problem for diagnosis and treatment.Keywords
This publication has 21 references indexed in Scilit:
- Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic PatientsBiomarker Insights, 2016
- Statistical Methods for Monitoring the Relationship between the IFCC Reference Measurement Procedure for Hemoglobin A1c and the Designated Comparison Methods in the United States, Japan, and SwedenClinical Chemistry, 2008
- Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications StudyClinical Chemistry, 2005
- IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison StudyClinical Chemistry, 2004
- Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) PerspectiveClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Approved IFCC Reference Method for the Measurement of HbA1c in Human BloodClinical Chemistry and Laboratory Medicine (CCLM), 2002
- Glycohemoglobin: A Primary Predictor of the Development or Reversal of Complications of Diabetes MellitusClinical Chemistry, 2001
- Standardization of HbA 1c measurements: a consensus statementAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2000
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes MellitusNew England Journal of Medicine, 1993